Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Makes Big Biologics Play For Alzheimer’s

This article was originally published in The Pink Sheet Daily

Executive Summary

But study published in Lancet raises questions about efficacy of anti-amyloid therapy.

You may also be interested in...



FDA, Pharma Need To Take Next Step In Alzheimer’s Imaging Tools

Even with consensus on a path forward for imaging agents to be validated for detection of amyloid-beta, there are still questions about the clinical utility of the agents and the potential path toward their use in diagnosis of, or prognosis for, Alzheimer's disease

FDA, Pharma Need To Take Next Step In Alzheimer’s Imaging Tools

Even with consensus on a path forward for imaging agents to be validated for detection of amyloid-beta, there are still questions about the clinical utility of the agents and the potential path toward their use in diagnosis of, or prognosis for, Alzheimer's disease

Start-Up Archer Preps Alzheimer’s Drugs For Phase I

IND filed, company aims to use nilvadipine derivative against soluble amyloid.

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel